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ABSTRACT
Along with amazing technological advances, the industrial revolution of the mid-19th century introduced new sources of
pollution. By the mid-20th century, the effects of these changes were beginning to be felt around the world. Among these
changes, health problems due to environmental air pollution are increasingly recognized. At the beginning, respiratory and
cardiovascular diseases were emphasized. However, accumulated data indicate that every organ system in the body may be
involved, and the kidney is no exception. Although research on air pollution and kidney damage is recent, there is now
scientific evidence that air pollution harms the kidney. In this holistic review, we have summarized the epidemiology,
disease states and mechanisms of air pollution and kidney damage.
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INTRODUCTION
The adverse health effects of ambient (outdoor) air pollution
have been recognized since increased mortality due to smog
was reported in London in 1952 [1, 2]. Since then, ambient air
pollution is recognized as one of the leading causes of global
disease burden [3, 4]. Air pollution is a complex mixture of gas-
eous components and solid and liquid particles suspended in
the air and can vary substantially in chemical composition be-
tween different cities. There are various sources of these pollu-
tants (Table 1).
Particulate matter (PM), which primarily comprises solid par-
ticles derived from the combustion of coal, gasoline and diesel
fuels, is the major element of air pollution that causes the most
adverse health effects [12, 13]. Environmental air pollution may
be composed of additional components (Figure 1), such as dif-
ferent sized PM (e.g. PM10 having an aerodynamic diameter
10 lm; PM2.5 which are 2.5 lm and PM2.5–10), gaseous pollu-
tants [e.g. nitrogen dioxide (NO2), carbon monoxide (CO), sul-
phur dioxide (SO2) and ozone (O3)] and heavy metals [e.g.
cadmium (Cd), lead (Pb) and mercury (Hg)] [14–16]. Over the past
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decade, a growing body of research has suggested a causal rela-
tionship between ambient air pollution exposure and adverse
cardiovascular health [17].
Chronic kidney disease (CKD) is another worldwide public
health problem with a variety of adverse outcomes, including
premature death, and it is regarded as a cardiovascular disease
(CVD) risk equivalent [18]. Apart from traditional risk factors,
such as hypertension and diabetes, an increasing body of evi-
dence demonstrates that air pollution may be a novel environ-
mental risk factor for CKD [5, 19, 20]. In the present review, we
systemically summarized the current data regarding air pollu-
tion and kidney disease.
METHODS
A literature search was performed using electronic databases
MEDLINE, Ovid/MEDLINE (1988–2018), PubMed/MEDLINE,
EMBASE and ISI Web/Web of Science for published studies from
January 1988 to March 2018. We searched for relevant studies
using the keywords ‘air pollution and chronic kidney disease’,
‘air pollution and end-stage renal disease’, ‘air pollution and
proteinuria’, ‘environmental pollution and chronic kidney dis-
ease’, ‘air pollution and diabetes’, ‘air pollution and hyperten-
sion’, ‘toxic metals and chronic kidney disease’ and ‘heavy
metals and chronic kidney disease’, limiting the search to re-
search articles involving humans and published in English.
Neither unpublished data nor abstracts were included.
NEPHROTOXIC METALS AND RENAL DISEASE
Heavy metals are among the best-known environmental pollu-
tants causing kidney disease. It is less well known that they are
also air pollutants, particularly Cd, Pb and Hg, but also arsenic
(As) and uranium (http://www.euro.who.int/__data/assets/pdf_
file/0007/78649/E91044.pdf).
Arsenic and CKD
Environmental, occupational and dietary exposure to As appear
to contribute to the incidence of renal injury and the
development of renal disease [11]. Contamination of drinking
water with As has been linked to the development of hyperten-
sion and renal injury [21, 22]. Findings from a cross-sectional
study of patients in Taiwan showed a positive correlation be-
tween urinary As and the incidence of CKD. It was concluded
that high levels of urinary As may increase the risk of develop-
ing CKD by 4-fold [23]. Acute As-induced renal intoxication may
lead to tubulointerstitial nephritis and acute tubular necrosis
manifested by hypercalciuria, albuminuria, nephrocalcinosis
and necrosis of the renal papillae [24, 25].
Cadmium and CKD
Cd is a prevalent nephrotoxic environmental pollutant. In non-
smokers, diet is the primary source for Cd exposure. However,
in smokers, the major source of exposure is related to tobacco
products that contain high concentration of Cd. As paediatric
Table 1. Major sources of common air and other environmental pollutants
Pollutant Source References
PM Mostly traffic-related air pollution (mainly local emission) [5, 6]
Other (domestic heating, industries, etc.)
NOX Mainly derived from road traffic and the industrial burning of fuels [7, 8]
Strongly related to diesel motor vehicles
SOX Industrial production of sulphur-based products [9]
O3 Industrial combustion and processes [10]
CO Road traffic and industrial fuel burning [7]
Cadmium Diet in non-smokers [11]
Tobacco in smokers
Lead Gasoline, batteries, pipes and ammunition [11]
In the past, paints and ceramic glazes
Occupational exposure to the inorganic form of Pb (Pb2þ): welding manufacture of Pb-containing
batteries, Pb melting and refining, and production of pottery
Children ingesting Pb2þ contaminated soil
Mercury Occupational, environmental and dietary sources [11]
Mainly through ingestion of food contaminated with CH3Hg
þ
Arsenic Primary route of human exposure is ingestion of contaminated drinking water [11]
Methylated forms of As (MAs and DMAs) from pesticides used in cotton crops
Uranium Mining and milling [11]
FIGURE 1: Components of environmental pollution.
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age increases, Cd exposure is also increased [26].
Environmental tobacco smoke exposure was the most important
determinant of Cd status in school-aged children. Moreover, se-
rum Cd levels were higher in active smoker teenagers than in
non-smokers. Interestingly, higher serum Cd concentration was
associated with higher alpha-1-microglobulinuria in adolescents,
suggesting subclinical renal toxicity after several years of cumu-
lative exposure [27]. Cd is also present in air and drinking water,
although the concentration of Cd in air is relatively low, and
drinking water is normally not a major source of exposure for the
general population. However, Cd contamination of drinking wa-
ter and vegetables has been observed in some cities and regions
[26]. Exposure to Cd is often assessed by measuring the concen-
tration of Cd in urine and/or blood. In fact, urinary Cd excretion
is considered as one of the most reliable indicators of renal and
body burden of Cd [11].
Cd is directly nephrotoxic and can induce renal tubular dam-
age (polyuria, generalized tubular dysfunction, i.e. Fanconi syn-
drome) and progressive loss of glomerular filtration rate (GFR)
[28–30]. Long-term Cd exposure is thought to accelerate the
CKD-related decline in GFR [31–33]. Cross-sectional studies have
shown that Cd exposure is a risk factor for the development of
CKD [34, 35]. Epidemiological studies have demonstrated a posi-
tive correlation between CKD and the renal accumulation of Cd
in individuals exposed chronically to this metal [36, 37]. The
most frequent long-term consequence of Cd exposure is pro-
teinuria, and it may precede a slowly progressive and irrevers-
ible renal tubular dysfunction [38]. Proteinuria has been
ascribed to the loss of megalin and cubilin, which mediate en-
docytosis of filtered proteins along the proximal tubule [39–41].
The incidence of kidney stones also increases in individuals ex-
posed chronically to or to larger Cd dose, possibly due to the in-
creased concentration of calcium in tubular fluid and urine [11].
Last but not least, Cd exposure has been associated with the se-
verity of diabetes [42] and hypertension [43], which themselves
are risk factors for CKD.
Lead and CKD
Together with bone, kidney is a primary site of Pb accumulation
as Pb is excreted by kidneys [44]. The major kidney cellular ef-
fect of exposure to Pb is the induction of mitochondrial oxida-
tive stress [45] and inflammation [11]. This results in lipid
oxidation and DNA fragmentation [46]. Low-level Pb exposure
early in life causes glomerular hypertrophy, which may disrupt
glomerular development [11]. Acute Pb intoxication causes
proximal tubular dysfunction (Fanconi syndrome) [47], and
chronic intoxication leads to progressive tubulointerstitial ne-
phritis [48]. There is convincing preclinical and clinical evidence
supporting a direct relationship between Pb exposure and
development of kidney disease [49, 50]. Additionally, cross-
sectional general population studies in Mexico and Korea
found a correlation between serum creatinine and blood Pb lev-
els [51, 52].
Mercury and CKD
All forms of Hg are nephrotoxic through various mechanisms.
Hg is well absorbed following inhalation, and air levels correlate
with exposure estimated by urinary Hg excretion. Hg has been
associated with CKD progression [11, 53]. The pars recta of the
proximal tubule appears to be most sensitive to the Hg toxicity
[54, 55]. Acute exposure causes altered mitochondrial structure,
endoplasmic reticulum dilation and nuclear pyknosis [56]. After
12 h, microvilli are lost and cell death is associated with plasma
membrane rupture and cell detachment from the basement
membrane [57].
Chronic exposure to mercuric compounds can lead to glomer-
ular injury [11]. In rats, chronic exposure to methyl Hg caused
glomerulosclerosis and glomerular immunoglobulin deposition.
In North West England, ambient background Hg concentration
(3 ng/m3) is higher than the average background level in the UK
(1.78 ng/m3). There were significant exposure–response relations
between modelled estimates of Hg exposure (low: >3 to <4; me-
dium: 4 to 10; high: >10; or very high exposure: >20 ng/m3) and
risk of kidney disease mortality in both men and women after
adjustment for age and socio-economic deprivation (test for
trend: P¼ 0.02 for men and P¼ 0.03 for women) [58]. In another
case–control study, occupational exposure in 272 men and
women with CKD was compared with 272 controls matched for
age, sex and region of residence. Hg exposure was independently
associated with an increased risk of CKD [odds ratio (OR) ¼ 5.13,
95% confidence interval (CI) 1.02–25.7] [59].
Uranium and CKD
Uranium toxicity, although relatively rare, may also cause renal
damage and indeed, the kidney is the primary target for ura-
nium toxicity following inhalation or ingestion. Approximately
40% of plasma uranium is complexed to transferrin and the
remaining 60% is complexed with carbonate or bicarbonate,
which are filtered by the glomerulus. In proximal tubules, the
complexed uranium dissociates with decreasing pH, releasing
the reactive uranyl ion, which can interact with the proximal tu-
bule membrane. The most frequently used guideline for ura-
nium kidney burdens is the International Commission on
Radiological Protection value of 3 mg/g, a value that is based
largely upon chronic animal studies [60]. A risk model equation
to assess potential outcomes of acute uranium exposure was
derived from 27 previously published case studies of acute ex-
posure to soluble uranium compounds in workplace accidents.
Kidney burdens of uranium for these individuals were deter-
mined from urine uranium, and correlated with health effects
observed over a period of up to 38 years. Based upon the severity
of health effects, each individual was assigned a score ( to 3þ)
and then placed into a Renal Effects Group (REG). A discriminate
analysis was used to build a model equation to predict the REG
based on the amount of kidney uranium [60] (Table 2).
TOBACCO AND CKD
Smoking is also an air pollutant detrimental for kidney health
[61]. A recent meta-analysis investigated the relationship be-
tween cigarette smoking and CKD in the general population.
Summary relative risks (SRRs) and 95% CIs were calculated us-
ing a random effects model. A total of 15 prospective cohort
studies, including 65 064 incident CKD cases, were included.
Compared with never-smokers, the SRRs of incident CKD were
1.34 (95% CI 1.23–1.47) for current smokers and 1.15 (95% CI
1.08–1.23) for former smokers. The SRRs for end-stage renal dis-
ease (ESRD) development were 1.91 (95% CI 1.39–2.64) for current
smokers and 1.44 (95% CI 1.00–2.09) for former smokers.
However, the authors noted that there was considerable hetero-
geneity among these studies [62]. In African Americans from
the Jackson Heart Study, after adjustment for various factors,
the incidence of renal function decline was higher in current
smokers than in never-smokers (incidence rate ratio 1.83, 95%
CI 1.31–2.56). Current smokers of 1–19 and 20 cigarettes daily
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had an increased incidence rate ratio of residual renal function
decline: 1.75 (95% CI 1.18–2.59) and 1.97 (95% CI 1.17–3.31), re-
spectively. In addition, there was a significant progressive re-
duction in estimated GFR (eGFR) from Visits 1 to 3 in current
and past smokers compared with never-smokers [63].
Apart from these findings, there is also evidence linking to-
bacco exposure to proteinuria in those with and without kidney
disease [64–67]. In 990 middle-aged men recruited from a chem-
ical plant, proteinuria was found in 4.6% of current smokers and
1.5% of never-smokers [68]. A meta-analysis of the relationship
between tobacco smoking on the development of diabetic ne-
phropathy (DN) in type 1 diabetes mellitus (T1DM) and T2DM,
identified 19 observational studies (1 case–control, 8 cross-
sectional and 10 prospective cohort studies), involving more
than 78 000 participants and a total of 17 832 DN cases. The rela-
tive risk (RR) (95% CI) of DN was higher in ever-smokers with
T1DM (1.31, 1.06–1.62; P¼ 0.006) or T2DM (1.44, 1.24–1.67;
P< 0.001) than in never-smokers. In T1DM ever-smokers, the RR
was 1.25 (95% CI 0.86–1.83) for microalbuminuria, 1.27 (95% CI
1.10–1.48) for macroalbuminuria and 1.06 (95% CI 0.97–1.15) for
ESRD. In T2DM ever-smokers, the RR was 1.46 (95% CI 0.94–2.26)
for microalbuminuria, 1.72 (95% CI 1.04–2.84) for macroalbumi-
nuria and 1.10 (95% CI 0.36–3.33) for ESRD [69]. Thus, it appears
that the highest risk associated with smoking is for macroalbu-
minuria, likely over a basis in incipient DN.
Passive smoking has also been associated with renal dam-
age. Assessment of the nicotine metabolite cotinine in serum
and in urine has been used to quantify smoking exposure. In a
cohort of 366 children with CKD aged 1–16 years, secondhand
smoke exposure obtained via questionnaire and urine cotinine
was associated with the prevalence odds of nephrotic range
proteinuria (OR ¼ 2.64, 95% CI 1.08–6.42) [70]. In active (n ¼ 24)
and passive (n ¼ 20) smokers, serum cotinine levels were
higher than in controls (n ¼ 20), as was the urinary albumin–
creatinine ratio, whereas serum creatinine was higher in active
smokers [71].
This evidence suggests that smoking harms the kidneys, but
how? Several mechanisms may be at play. Cigarette smoking
has been associated with idiopathic nodular glomerulosclerosis
and microalbuminuria or overt proteinuria in healthy individu-
als, and with more severe proteinuria in individuals with pre-
existing renal disease such as DN [72–74]. A correlation between
smoking and nephrosclerosis and glomerulonephritis was
found in a nationwide population-based case–control study
that included Swedish subjects, 926 cases and 998 control [75].
Smoking promoted the progression of hypertensive [67, 76] and
diabetic nephropathies [77]. Cigarette smoking has been directly
associated with endothelial dysfunction, intimal hyperplasia
and wall thickening of myocardial and renal arterioles and
arteries.
Tobacco smoke caused mesangial proliferation, glomerulo-
sclerosis and tubulointerstitial fibrosis in experimental studies
[72, 78]. Specifically, nicotine activation of nicotine receptors
promotes human mesangial cell extracellular matrix
production [79]. Acrolein, an aldehyde from tobacco smoke,
induces renal cell reactive oxygen species (ROS) production and
apoptosis [80, 81]. Smoking also increases Cd levels and this
could contribute to CKD progression. Smokers have 4- to 5-fold
higher Cd levels in blood and 2- to 3-fold higher kidney Cd than
non-smokers [82]. Indeed, NHANES 1999–2006 data for adults
without CKD showed that urine Cd levels were highest for cur-
rent smokers (3- to 13-fold higher), followed by former smokers
(2- to 3-fold) compared with non-smokers. Cigarette smoking
greatly increases RR of exceeding renal risk-associated urine Cd
levels, particularly in former smokers [28].
Passive smoking has also being associated with renal fibro-
sis. Glomerulosclerosis comparable to the findings in idiopathic
nodular glomerulosclerosis in human beings and upregulation
of interstitial fibrosis-related genes has been observed in the ab-
sence of proteinuria, suggesting that histological changes pre-
cede biochemical changes [26]. Elevated sympathetic activity,
blood pressure (BP), GFR and intraglomerular capillary pressure
are candidate mechanisms for smoking-induced renal damage
[72]. It was also suggested that chronic environmental tobacco
smoke exposure induces systemic oxidative stress, which may
subsequently trigger production of profibrotic factors [83].
However, there are also contradictory findings. In healthy
rats exposed to smoke soon after birth for 4 months, as a model
of passive smoking, the mean number of renal vessels, glomer-
ulosclerosis and myointimal hyperplasia did not significantly
differ from control rats [84]. However, it is unclear whether the
timing was appropriate to observe any effect. No differences
were found in the prevalence of glomerulosclerosis between
non-smokers (51 patients, 47.7%) and ever-smokers (56 patients,
52.3%) in kidney biopsy. However, the number of glomeruli
obtained at biopsy may have been insufficient for assessing glo-
merulosclerosis [85].
TRAFFIC AND NEARBY INDUSTRIAL
POLLUTION AND CKD
Traffic air pollution is another kind of air pollution. Among 8497
Taipei city residents, regression models were used to estimate
the participants’ 1-year exposures to PM of different sizes and
traffic-related exhaust, PM2.5 absorbance, NO2 and nitrogen oxi-
dases (NOx). Interquartile range (IQR) increments of PM2.5 absor-
bance (0.4  105/m) and NO2 (7.0 mg/m3) were associated with
1.07 and 0.84% lower eGFR, respectively. Similar associations
were also observed for PM10 and PM2.5–10. Two-pollutant models
showed that PM10 and PM2.5 absorbances were associated with
lower eGFR. Authors conclude that 1-year exposures to traffic-
related air pollution were associated with lower eGFR, higher
CKD prevalence and increased risk of CKD progression among
the elderly. Of note, there were no significant findings with re-
gard to proteinuria, but albuminuria was not assessed [5].
Among 1103 consecutive Boston-area patients hospitalized with
acute ischaemic stroke between 1999 and 2004, linear regression
Table 2. Acute renal effects and predicted outcomes of kidney uranium accumulation
REG Kidney uranium concentration (mg/g) Acute renal effect Predicted outcome
0 2.2 None No clinically detectable effects
1 >2.2 to 6.4 Possible transient indicators of renal dysfunction Not likely to become ill
2 >6.4 to 18 Possible protracted indicators of renal dysfunction May become ill
3 >18 Possible severe clinical symptoms of renal dysfunction Likely to become ill
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was used to evaluate the association between eGFR and catego-
ries of residential distance to major roadway (0 to 50, 50 to
100, 100 to 200, 200 to 400, 400 to 1000 and >1000 m)
adjusting for age, sex, race, smoking, comorbid conditions,
treatment with angiotensin-converting enzyme inhibitor and
neighbourhood-level socioeconomic characteristics. Patients
living closer to a major roadway had lower eGFR than patients
living farther away (Ptrend ¼ 0.01). Comparing patients living
50 m versus 1000 m from a major roadway, patients living
within 50 m had 3.9 mL/min/1.73 m2 lower eGFR (95% CI 1.0–6.7;
P¼ 0.007), a difference comparable in magnitude to the reduc-
tion in eGFR observed for a 4-year increase in age in population-
based studies. The magnitude of this association did not differ
significantly across categories of age, sex, race, history of hyper-
tension, diabetes or socioeconomic status. However, as this
study involved patients who were hospitalized with acute
ischaemic stroke, the generalizability of the results to the gen-
eral population is questionable. Proteinuria was not studied
[86]. Excess kidney disease mortality was found in persons liv-
ing within 2 km of industrial plants potentially releasing renal
toxicants in Runcorn, UK: the standardized mortality ratio
in males was 131 (95% CI 90–185) and in females 161 (95% CI
118–214) compared with a reference population living at 2.01–
7.5 km [87].
PM AND CKD: EPIDEMIOLOGIC STUDIES
There are many studies showing association with various PM
and CKD. A weak acceleration in the progression of albuminuria
was observed during chronic exposure to PM10 in Multi-Ethnic
Study of Atherosclerosis cohort [88]. In China, long-term expo-
sure to PM2.5 was associated with an increased risk of membra-
nous nephropathy in a nonlinear pattern in 71 151 native
kidney biopsy samples from 938 hospitals in 282 cities. During
the study period, PM2.5 exposure varied from 6 to 114 lg/m
3
(mean 52.6 lg/m3) among the 282 cities. Each 10 lg/m3 increase
in PM2.5 concentration was associated with 14% higher odds of a
patient developing membranous nephropathy (OR ¼ 1.14, 95%
CI 1.10–1.18) in regions with PM2.5 levels >70 lg/m
3, but the
effect size in regions with PM2.5 <60 lg/m
3 was greatly attenu-
ated [89].
Another longitudinal observational cohort study that en-
rolled 2 482 487 US veterans demonstrated the association of
PM2.5 concentrations with higher risk of incident CKD and pro-
gression to ESRD [90]. One-year PM2.5 exposure was associated
with a lower eGFR among older men [91]. Among 21 656
Taiwanese adults, individual exposures to PM10, coarse particles
(PMcoarse) or PM2.5 were related to renal function. An IQR in-
crease in PM10 (5.83 lg/m
3) was negatively associated with eGFR
by –0.69 (95% CI –0.89 to –0.48) mL/min/1.73 m2 and positively
associated with the prevalence of CKD with adjusted OR ¼ 1.15
(95% CI 1.07–1.23). An IQR increase in PMcoarse (6.59 lg/m
3) was
significantly associated with lower eGFR by –1.07 (95% CI –1.32
to –0.81) mL/min/1.73 m2 and with CKD with OR ¼ 1.26 (95% CI
1.15–1.38). In contrast, neither outcome was significantly associ-
ated with PM2.5. Stratified analyses indicated that associations
of CKD with both PM10 and PMcoarse were limited to participants
<65 years of age and were stronger in (for PM10) or limited to
(PMcoarse) women. Associations also appeared to be stronger in
those without hypertension than in those with hypertension,
and in normal versus overweight participants [19].
In a recent cohort study, Bowe et al. [92] investigated the
associations regarding coarse PM, NO2 and CO with the risk of
kidney disease. The authors evaluated the association between
PM10, NO2 and CO concentrations and risk of incident eGFR of
<60 mL/min/1.73 m2, incident CKD, eGFR decline of 30% and
ESRD. Participants were followed-up over a median of 8.52 years
(IQR: 8.05–8.80). This study is one of the biggest, involving
2 010 398 participants. Among those individuals, the median
concentration for PM10 was 20.45 lg/m
3 (IQR: 14.64–24.81), NO2
was 14.54 parts per billion (9.69–17.91) and CO was 0.51 parts per
million (0.40–0.64). An increased risk of eGFR <60 mL/min/
1.73 m2 was associated with an IQR increase in concentrations
of PM10 [hazard ratio (HR) ¼ 1.07, 95% CI 1.06–1.08], NO2 (HR ¼
1.09, 95% CI 1.08–1.10) and CO (HR ¼ 1.09, 95% CI 1.08–1.10). An
increased risk of incident CKD was associated with an IQR in-
crease in concentrations of PM10 (HR ¼ 1.07, 95% CI 1.05–1.08),
NO2 (HR ¼ 1.09, 95% CI 1.08–1.11) and CO (HR ¼ 1.10, 95% CI 1.08–
1.11). An increased risk of an eGFR decline of 30% was associ-
ated with an IQR increase in concentrations of PM10 (1.08, 95%
CI 1.07–1.09), NO2 (1.12, 95% CI 1.10–1.13) and CO (1.09, 95% CI
1.08–1.10). An increased risk of ESRD was associated with an IQR
increase in concentrations of PM10 (1.09, 95% CI 1.06–1.12) and
NO2 (1.09, 95% CI 1.06–1.12). This study, which has a high statis-
tical power, showed that higher concentrations of PM10, NO2
and CO are associated with increased risk of incident CKD, eGFR
decline and ESRD [92].
AIR POLLUTION AND BP
Air pollution has been associated with increased cardiovascular
morbidity and mortality in numerous epidemiological studies.
One of the proposed mechanisms involves increased BP, which
is a risk factor for the development of CKD [93]. Large population
studies showed that higher PM levels are associated with higher
BP levels, even based on one BP measurement [94–99]. Data
from the Nurses’ Health Study revealed that exposure to PM10
was associated with a slight increased risk of incident self-
reported hypertension (PM10, HR 1.02, 95% CI 1.00–1.04) [100].
Similar findings were also observed in a Taiwanese study,
which found that long-term exposure to PM2.5 was associated
with increased risk of hypertension [101]. In another study,
among 24 845 adults in Northeastern China, long-term exposure
to air pollution was associated with increased odds of hyperten-
sion and more strongly with prehypertension [102].
Additionally, a recent systematic review and meta-analysis
reported a positive association between ambient air pollution
and elevated odds of hypertension [95, 103–108].
Apart from these studies, a very recent meta-analysis
searched for the global association between ambient air pollu-
tion and BP. Seven international and Chinese databases encom-
passing 0.7 million participants from 16 countries were
searched for studies examining the associations of PM2.5,
PM2.5–10 or PM10 and gaseous (SO2, NO2, NOx, O3, CO) air pollu-
tants with hypertension or BP. The overall meta-analysis
showed significant associations of long-term exposures to PM2.5
with hypertension (OR ¼ 1.05), and of PM10, PM2.5 and NO2 with
diastolic BP (b-values: 0.47–0.86 mmHg). In addition, short-term
exposures to four (PM10, PM2.5, SO2, NO2), two (PM2.5 and SO2)
and four air pollutants (PM10, PM2.5, SO2 and NO2) were signifi-
cantly associated with hypertension (ORs ¼ 1.05–1.10), systolic
BP (b-values: 0.53–0.75 mmHg) and diastolic BP (b-values: 0.15–
0.64 mmHg), respectively. Stratified analyses showed a gener-
ally stronger relationship among men, Asians, North
Americans and areas with higher air pollutant levels [103].
Additional studies have observed that not only single BP meas-
urements but repeated BP measurements are also related to
PM levels [106, 109–111].
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An analysis of the association of exposure to PM10 (average
concentration 23.5613.6mg/m3) with ambulatory BP and with
sodium excretion in 359 adults disclosed that after controlling
for potential confounders, a 10 mg/m3 increase in PM10 levels
was positively associated with nighttime systolic BP, nighttime
diastolic BP and negatively associated with nocturnal systolic
BP dipping and daytime urinary sodium excretion, but not with
nighttime sodium excretion. The effect sizes per 10 mg/m3 of
PM10 were in the order of 1.0 mmHg for nighttime systolic BP
and 0.5 mmHg for nighttime diastolic BP. The associations of
short-term increase in PM10 with higher nighttime BP and
blunted systolic BP dipping were preceded by associations with
reduced ability of the kidney to excrete sodium during daytime.
The authors suggested that the underlying mechanism linking
air pollution to increased cardiovascular risk may include dis-
turbed circadian rhythms of renal sodium handling and BP
[112]. Smaller studies (48 healthy vehicular traffic controllers
and 10 patients with impaired lung function) did not find any
association between air pollution and ambulatory BP [113, 114].
Air pollution has also been associated with BP in children. A
study of Chinese children aged 5–17 years found a positive asso-
ciation between short-term (2 years) exposure to ambient air
pollution and elevated BP [115]. The interaction between expo-
sure to pet ownership and air pollutants on hypertension was
studied in 9354 Chinese children (aged 5–17 years) from 24 ele-
mentary and middle schools during 2012–13. Four-year average
concentrations of PM10, SO2, NO2 and O3 were collected from
2009 to 2012. Hypertension was defined as average diastolic or
systolic BP (three measurements) in the 95th percentile or
higher based on height, age and sex. Children not exposed to
pets exhibited consistently stronger effects of air pollution than
those exposed to pets. The highest ORs per 30.6 mg/m3 increase
in PM10 were 1.79 (95% CI 1.29–2.50) in children without current
pet exposure compared with 1.24 (95% CI 0.85–1.82) in children
with current pet exposure. As for BP, only O3 had an interaction
for all exposure to pet ownership and showed lower BP in chil-
dren exposed to pets. The increases in mean diastolic BP per
46.3 mg/m3 increase in O3 were 0.60 mmHg (95% CI 0.21–0.48)
in children without pet exposure in utero compared with
0.34 mmHg (95% CI 0.21–0.48) in their counterparts. When strati-
fied by age, pet exposure was more protective among younger
children. This suggests that pet ownership reduces susceptibil-
ity to the health effects of pollutants [17].
However, there are also conflicting findings. For instance, a
meta-analysis that examined the association between long-
term exposure to air pollution and arterial BP in the European
Study of Cohorts for Air Pollution Effects (n ¼ 164 484) revealed
that NO2 exposure was associated with a weak inverse relation-
ship with systolic BP (0.29; 95% CI 0.70 to 0.12) among individu-
als not taking BP-lowering medication [116]. There are also
some studies that found either no association [113, 117] or a
negative association [118] of PM with BP. It should be noted that
these negative studies are smaller in number and a large body
of evidence still suggests a positive correlation between air pol-
lution and hypertension.
AIR POLLUTION AND DIABETES
Diabetes is an ever-increasing worldwide health problem.
Systematic reviews, meta-analyses and epidemiological studies
confirm that exposure to air pollution may be associated with
the incidence or prevalence of DM [119–124]. Several cohort
studies also showed greater T2DM risk with exposure to higher
levels of NO [125, 126] and PM2.5 [127, 128].
The effect of long-term exposure to ambient PM on the prev-
alence of T2DM and hypertension was explored in Iranian
adults grouped by PM10 concentration <100 lg/m
3 (5-year
average 83.9567.81 lg/m3) or >100 lg/m3 (5-year average
120.156 6.81 lg/m3). The prevalence of T2DM (13.8% versus
10.7%, P¼ 0.01; OR ¼ 1.32, 95% CI 1.03–1.69) and hypertension
(15.7 versus 11.9%, P¼ 0.005; OR ¼ 1.55, 95% CI 1.20–1.99) was
higher in the city with higher PM10 exposure [129]. The associa-
tion between long-term exposure to PM, NOx and O3 and base-
line prevalence and incidence of T2DM was also studied in a
large administrative cohort in Rome, Italy. A total of 1 425 580
subjects aged 35þ years in January 2008 were assessed and fol-
lowed for 6 years. A positive association was found between
NOx exposures and prevalence of diabetes with ORs up to 1.010
(95% CI 1.002–1.017) and 1.015 (95% CI 1.009–1.021) for NO2 and
NOx, respectively, per 10 lg/m
3 and 20 lg/m3. They also found
some evidence of an association between NOx and O3 and inci-
dence of diabetes with HRs of 1.011 (95% CI 1.003–1.019) and
1.015 (95% CI 1.002–1.027) per 20 and 10 lg/m3 increases, respec-
tively. The association with O3 with incident diabetes was
stronger in women than in men and among those aged
<50 years [6]. However, no association was found between PM10,
PM2.5 or PM2.5–10, and diabetes. In the Netherlands, long-term
exposure to NO2 was associated with prevalence of diabetes (OR
¼ 1.07, 95% CI 1.05–1.09 per IQR increases) after adjustment for
individual confounders such as body mass index (BMI) and
physical activity [130].
In a very large-scale prospective study involving 1 729 108
participants who were followed-up for a median of 8.5 years,
the relationship between PM2.5 and the risk of incident diabetes
was investigated. All models were adjusted for age, race, sex,
eGFR, systolic BP, hyperlipidaemia, chronic lung disease, CVD,
cancer, BMI, smoking status, use of an angiotensin-converting
enzyme inhibitor or angiotensin receptor blocker and other
covariates. In adjusted models, a 10 mg/m3 increase in PM2.5 was
associated with increased risk of diabetes (HR ¼ 1.15, 95% CI
1.08–1.22). The authors concluded that there is a significant as-
sociation between increased PM2.5 exposure and the risk of dia-
betes with variable geographical distribution. More importantly,
the risk is significant at concentrations below those recom-
mended by regulatory agencies. This suggests that even a low
concentration of air pollution might be unsafe, and adverse
effects of air pollution become obvious at relatively low concen-
trations below those currently considered as safe by regulatory
agencies [131]. In 429 overweight and obese African American
and Latino Los Angeles children, both NO2 and PM2.5 were asso-
ciated with higher fasting glycaemia and insulin, lower insulin
sensitivity and higher insulin secretion. Specifically, each SD in-
crease in NO2 and PM2.5 exposure was associated with 22.8%
(P< 0.001) and 24.7% (P< 0.001) higher fasting insulin, respec-
tively. At the same time, each SD increase in NO2 and PM2.5 ex-
posure was associated with a 1.6% (P< 0.001) and 1.6%
(P< 0.001) higher fasting glucose, respectively. HOMA-IR was
25.1% (P< 0.001) and 26.9% (P< 0.001) higher and insulin sensi-
tivity 8.5% (P¼ 0.03) and 11.2% (P¼ 0.003) lower for each SD in-
crease in NO2 and PM2.5 exposure. Regarding adiposity
estimates, only elevated annual exposure to PM2.5 was associ-
ated with a higher BMI z-score (b¼ 0.05; P¼ 0.04). Each SD in-
crease in non-freeway NOx exposure was related to a 12.1%
higher fasting insulin (P< 0.001), 0.7% higher fasting glucose
(P¼ 0.047), 12.9% higher HOMA-IR (P< 0.001) and 6.9% lower in-
sulin sensitivity (P¼ 0.02) [132]. In a large American cohort
(Cancer Prevention Study-II participants), a strong effect of
ozone on diabetes-related mortality was found (HR ¼ 1.16, 95%
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CI 1.07–1.26 per fixed increment of 10 parts per billion, equal to
20 lg/m3 O3) [133]. Rats exposed to realistic concentrations of
ozone (0.8 parts per million ¼ 1.69 lg/m3) developed insulin re-
sistance induced by c-Jun N-terminal kinase activation that dis-
rupted insulin signalling in skeletal muscles, suggesting a
cause-and-effect relationship between ozone and insulin resis-
tance [134]. The association of long-term residential exposure to
PM2.5 with the prevalence and incidence of T2DM was studied in
61 447 elderly Hong Kong residents enrolled in 1998–2001, fol-
lowing participants without DM at baseline to 31 December 2010
to ascertain the first hospital admissions for T2DM. Over a mean
follow-up of 9.8 years, 806 incident cases of T2DM occurred. After
adjusting for potential confounders, the OR for every IQR (3.2lg/
m3) increase of PM2.5 concentration was 1.06 (95% CI 1.01–1.11)
for prevalent DM, while the corresponding HR was 1.15 (95% CI
1.05–1.25) for incident T2DM [135]. These findings were in accor-
dance with prior finding regarding PM2.5 and DM [136, 137] and
with prospective cohort studies that examined the effect of long-
term PM2.5 exposure on T2DM incidence [125, 127, 128].
Although all these findings suggest a strong relationship be-
tween air pollution and DM, some conflicting findings exist.
Exposure to SO2 and PM10 was significantly related to the preva-
lence of T2DM in women, but not in men, suggesting gender dif-
ferences [122]. Other prospective cohort studies also low in
numbers failed to observe statistically significant associations
between long-term PM2.5 exposure and incident DM [126, 138].
In the Framingham Offspring cohort, participants living 64 m
(25th percentile) from a major roadway had 0.28% (95% CI 0.05–
0.51%) higher fasting plasma glucose than participants living
413 m (75th percentile) away, and the association appeared to
be driven by participants who lived within 50 m from a major
roadway. Higher exposures to 3- to 7-day moving averages of
black carbon and NOx were associated with higher plasma glu-
cose, whereas the associations for ozone were negative, but
there was no association with insulin resistance as evaluated
by the HOMA-index [139].
Generally, in short-term exposure studies, exposure to air
pollution was associated with higher levels of glucose, insulin
or HOMA-IR [140, 141], whereas in longer term exposure, most
of the positive associations were found with glucose but not
with insulin or HOMA-IR [142, 143].
MESOAMERICAN NEPHROPATHY
MesoAmerican nephropathy (MeN) is another recently recog-
nized endemic form of CKD. MeN can be considered as an envi-
ronmental disease since it mostly affects people working in
agricultural areas and with a tendency to be found in specific
geographical locations, such as Nicaragua and El Salvador and
other Central American countries. Additionally, global warming
is thought to contribute to the increased incidence of MeN.
Patients with MeN present with elevated creatinine levels, no
hypertension and urine albumin levels are normal or of non-
nephrotic range. The cause and pathogenesis of MeN are still
not fully known; however, the repeated dehydration hypothesis
is thought to play a role in the development of kidney disease.
In this scenario, occupational heat exposure with repeated epi-
sodes of volume and salt depletion occurs during the disease
process. Potential mechanisms include the development of
hyperosmolarity with the activation of the aldose reductase–
fructokinase pathway in the proximal tubule leading to local in-
jury and inflammation, and the possibility that renal injury
may be the consequence of repeated uricosuria and urate
crystal formation as a consequence of both increased genera-
tion and urinary concentration, similar to a chronic tumour
lysis syndrome. The epidemic is postulated to be increasing due
to the effects of global warming. The renal morphology shows
glomerulosclerosis of varying degrees, glomerular hypertrophy
and signs of chronic glomerular ischaemia, together with mild
to moderate chronic tubulointerstitial damage [131, 144, 145]. As
MeN is considered as an environmental disease due to global
warming, interventional studies to reduce heat stress may be of
great importance. Indeed, a recent Phase 1 study showed that
after an intervention with sugarcane workers, self-reported wa-
ter consumption increased 25% and symptoms associated with
heat stress and dehydration decreased [146]. It is now evident
that new health problems with environmental and climate
changes such as MeN will be of more interest in the near future,
and preventive measures will be of the utmost importance for
the prevention of a MeN epidemic.
BALKAN ENDEMIC NEPHROPATHY AND
CHINESE HERB NEPHROPATHY
Balkan endemic nephropathy (BEN) is a kind of endemic ne-
phropathy associated with upper urethelial cancer with specific
geographical distribution along tributaries of the Danube River
in Bosnia–Herzegovina, Croatia, Macedonia, Serbia, Bulgaria
and Romania. Several hypotheses on the cause of BEN have
been suggested such as mycotoxins, heavy metals, viruses and
trace element insufficiencies. However, recent evidence sug-
gests that chronic dietary exposure to aristolochic acid (AA)—a
principal component of Aristolochia clematitis—which grows as a
weed in the wheat fields of the endemic regions—is the cause of
BEN [147].
BEN is described as a familial clustering and a slowly pro-
gressive kidney disease. The clinical signs and symptoms of
BEN are non-specific and often remain latent for years and even
decades. After an initial asymptomatic stage, patients suffer
from weakness and lassitude, mild lumbar pain and pallor of
the skin. At a later stage, anaemia is associated with a signifi-
cant loss of renal function. Proteinuria of tubular type and spe-
cifically, b2-microglobulinuria is observed. Histologically, BEN is
characterized by tubular atrophy with extensive hypocellular
fibrosis decreasing from the outer to the inner cortex of the kid-
ney [148, 149]. Nowadays, BEN is considered as an environmen-
tal disease since environmental exposure to AA by BEN patients
has been confirmed [150, 151]. Other evidence of BEN being an
environmental disease comes from the fact that in the last few
decades, exposure to AA has decreased due to the significant
improvement in farming and milling practices, disabling and
preventing the contamination of flour [152].
Chinese herb nephropathy (CHN) is another nephropathy
that is also related to AA. This nephropathy appeared to be the
dramatic consequence of a substitution of Stephania tetrandra by
Aristolochia fangchi, which is rich in AA, because both herbs
share the same common name and one can be used instead of
the other in traditional Chinese medicine irrespective of their
botanical classification. The true incidence of aristolochic acid
nephropathy (AAN) is largely unknown and probably underesti-
mated, as numerous ingredients known or suspected to contain
AA are used in traditional medicine in China, Japan and India.
CHN is characterized by a rapidly progressive interstitial nephri-
tis, leading to ESRD and urothelial malignancy [153]. In most of
the cases, urinary sediment was unremarkable, and dipstick
analysis for albuminuria was negative. Macroscopically, the
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kidneys were shrunk, asymmetric in about half of the cases
with irregular outlines in one-third [154].
Microscopically, an extensive interstitial fibrosis with atro-
phy and loss of proximal tubules was the predominant lesion,
which was mainly located in the superficial cortex and pro-
gressed towards the deep cortex. The glomeruli were relatively
spared, although, in the later stage of the disease, they dis-
played a mild collapse of the capillaries and a wrinkling of the
basement membrane [155]. Some suggest that BEN and CHN
can be considered as two faces of Janus; however, recent evi-
dence suggests that except in specific cases of acute tubular ne-
crosis, no similarity could be found in the tubulointerstitial
compartment with histological lesions observed in BEN and
CHN [153]. However, as discussed above, both BEN and CHN can
be considered as specific forms of nephropathy with specific
geographical distribution.
PATHOGENESIS
Several mechanisms have been proposed to link exposure to air
pollution with BP and kidney damage (Figure 2). Inhaled PM can
trigger acute autonomic nervous system imbalance and sys-
temic proinflammatory responses and can activate vascular en-
dothelial dysfunction and arterial vasoconstriction [156, 157].
Impaired sodium excretion associated with PM [112] may also
increase BP since an impaired capacity to excrete sodium during
daytime would lead to a non-dipping pattern [158]. Long-term
exposure to traffic pollution leads to vascular endothelial injury,
systemic inflammation, atherosclerosis and microvascular
changes [13, 159]. Evidence from Apo-E knockout mice and
hyperlipidaemic rabbits indicates that long-term exposure to
urban air pollution causes increased atherosclerosis with in-
flammatory characteristics [160, 161]. Moreover, in community-
dwelling adults, traffic-related pollution is positively associated
with carotid intima–media thickness [162, 163]. Mice chronically
and continuously exposed to ambient levels of air pollution for
4 months developed significant more thickening (decreased lu-
men/wall ratios) in pulmonary and coronary arteries than mice
exposed to filtered air in which PM10 and NO2 were reduced by
50 and 75%, respectively. However, no evidence of influence of
air pollution was detected in intra parenchymal renal arteries,
which are well-known targets of systemic hypertension. One
possibility is that pulmonary and cardiac effects were promoted
by highly reactive substances present in the air, which may not
reach sufficiently high levels in the renal circulation [164]. A re-
cent experimental study reported that 16 weeks of exposure to
concentrated ambient PM (average 13.3 lg/m3) versus filtered air
was positively associated with glomerulosclerosis in rat T1DM
[165]. Air pollution has been associated with objective markers
of cardiovascular risk, such as circulating white cell counts,
plasma fibrinogen levels and decreased heart rate variability
FIGURE 2: Pathogenic mechanisms of environmental pollutants leading to kidney damage. WBC, white blood cell.
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[166, 167]. PM has been reported to be associated with increased
plasma viscosity [168], changes in blood characteristics [169]
and indicators of abnormal autonomic function of the heart, in-
cluding increased heart rate, decreased heart rate variability
and increased cardiac arrhythmias [170].
Smoking is an independent risk factor for CKD and might
result in intraglomerular hypertension, vascular damage or
glomerulosclerosis via multiple complex interactions of non-
haemodynamic (angiotensin II, transforming growth factor-b1,
endothelin-1) and haemodynamic factors [171], and occupa-
tional exposures to Cd and Pb may affect the magnitude of kid-
ney damage conferred by smoking [172].
An interaction with obesity has also been described.
Concentrated PM and ozone exposures induced inflammation
and oxidative stress in peri-renal adipose tissue in rats [173].
Ambient fine PM matter may exaggerate adipose inflammation,
induce insulin resistance and oxidative stress, mitochondrial
functions and gene expression in adipose tissue [174–176].
Furthermore, diabetes and obesity may enhance the associa-
tions between PM2.5 and biomarkers of systemic inflammation
[177], which in turn would lead to diminished insulin action
[178]. Air pollution may also be associated with dysregulated
release of peptides or proteins (adipokines) secreted by
adipose tissue that regulates carbohydrate metabolism [174,
175, 179]. Mice exposed to PM2.5 developed a non-alcoholic
steatohepatitis-like phenotype of impaired hepatic glycogen
storage, glucose intolerance and insulin resistance. Moreover,
exposure to PM2.5 activated inflammatory response pathways
mediated through cJun N-terminal kinase, nuclear factor kappa
B and toll-like receptor 4, and suppressed the insulin receptor
substrate 1-mediated signalling [180].
RESEARCH NEEDS
The detrimental effects of air pollution on the kidney have just
begun to be acknowledged. Various pollutants (toxic metals,
PM, cigarette smoke and gases) may harm the kidney. However,
it is not exactly known which pollutant by itself specifically
causes damage or what type of damage.
Despite all accumulating data regarding pollution and its ad-
verse health effects, there are still gaps that have to be recog-
nized. This issue is very important since pollution is a global
health threat that was responsible for an estimated 9 million
premature deaths as well as for 268 million disability-adjusted
life-years in 2015, which means great economic losses. The ma-
jority—71%—of the deaths attributed to pollution are caused by
non-communicable diseases. To end neglect of pollution and
advance prevention of pollution-related disease, commissions
have been formed such as the Lancet Commission on Pollution
and Health. The Commission identified substantial gaps in
knowledge about pollution and noted that these gaps result in
underestimation of pollution’s contribution to the global burden
of disease. To close these gaps and guide prevention, the
Commission made research recommendations and proposed
creation of a Global Observatory on Pollution and Health. It is of
no doubt that successful pollution research needs transdisci-
plinary collaborations among exposure science, epidemiology,
data science, engineering, health policy and economics. Studies
must be stimulated regarding the burden of disease due to pol-
lution in cities and countries that include options for pollution
control and disease prevention, source apportionment studies
that analyse the amounts of pollution, country-level analyses of
the burden of disease and loss of human capital attributable to
various pollutants and all pollution in specific countries. These
studies are essential for identifying the pollution sources with
the most significant effects on human health and for prioritiz-
ing interventions [181].
Besides these issues, specific mechanisms of kidney injury
are not known. PM is a complex mixture of chemical com-
pounds, the behaviour of which strongly depends on the atmo-
spheric conditions. Furthermore, it is not clear regarding the
mechanisms that lead to development of CKD. For example,
PM2.5 is associated both with DM and hypertension. However, it
is not clear how much of the association of PM2.5 to CKD devel-
opment is attributed to DM and hypertension separately. These
issues are important to plan preferential preventive measures
according to dominant-associated mechanisms. Last but not
the least, more needs to be known about the causal relationship
between exposure to levels of environmental pollution and ulti-
mately cause-specific mortality. Further studies are needed to
explore which compound(s) within PM might be responsible for
the observed associations and what manoeuvres may prevent
or treat these adverse effects.
Prospective studies should explore whether improving air
pollution, setting preventive measures for clean air and using
green energy have beneficial effects on hard endpoints, such as
reduction in the incidence of diabetes, hypertension and CKD.
Additionally, more longitudinal studies in different parts of the
world with different pollution levels are needed to directly com-
pare the effects of air pollution on human health. Recent initia-
tives to restrict the use of diesel fuels for urban transportation
in Europe offer the opportunity to design and fund such studies.
CONCLUSION
The classic view that air pollution is a risk factor for upper and
lower respiratory airways is now challenged by evidence that
air pollution may also impact other organs such as heart, ves-
sels and kidneys. The inflammatory mediators induced by PM
and other pollutants in the lungs could spill over into the circu-
lation, resulting in systemic inflammation, oxidative stress and
damage to distant organs including kidneys [13]. However, there
is also evidence of direct harm to the kidneys. The pathogenesis
is still not fully understood. Studies are needed to characterize
which type of air pollutant is primarily responsible for specific
disease processes. It is necessary to raise awareness and recruit
into action policy-makers, industry representatives establishing
air quality standards, emissions controls and promoting the use
of greener energy. More detailed longitudinal studies and also
experimental designs are needed to demonstrate cause-and-
effect relationships between specific air pollutants and kidney
damage as well as the impact of manoeuvres that decrease air
pollution.
CONFLICT OF INTEREST STATEMENT
None declared.
REFERENCES
1. Bell ML, Davis DL. Reassessment of the lethal London fog of
1952: novel indicators of acute and chronic consequences
of acute exposure to air pollution. Environ Health Perspect
2001; 109 (Suppl 3): 389–394
2. Park SK. Ambient air pollution and type 2 diabetes: do the
metabolic effects of air pollution start early in life? Diabetes
2017; 66: 1755–1757
Air pollution and kidney disease | 27
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/1/19/5162583 by U
niversidad Autonom
a de M
adrid user on 14 O
ctober 2019
3. Global, regional, and national comparative risk assessment
of 79 behavioural, environmental and occupational, and
metabolic risks or clusters of risks, 1990-2015: a systematic
analysis for the Global Burden of Disease Study 2015. Lancet
2016; 388: 1659–1724
4. Brook RD, Newby DE, Rajagopalan S. The global threat of
outdoor ambient air pollution to cardiovascular health:
time for intervention. JAMA Cardiol 2017; 2: 353–354
5. Chen SY, Chu DC, Lee JH et al. Traffic-related air pollution
associated with chronic kidney disease among elderly resi-
dents in Taipei City. Environ Pollut 2018; 234: 838–845
6. Renzi M, Cerza F, Gariazzo C et al. Air pollution and occur-
rence of type 2 diabetes in a large cohort study. Environ Int
2018; 112: 68–76
7. Kelly FJ, Fuller GW, Walton HA et al. Monitoring air pollu-
tion: use of early warning systems for public health.
Respirology 2012; 17: 7–19
8. Renzi M, Stafoggia M, Faustini A et al. Analysis of temporal
variability in the short-term effects of ambient air pollu-
tants on nonaccidental mortality in Rome, Italy (1998-
2014). Environ Health Perspect 2017; 125: 067019
9. Kellogg WW, Cadle RD, Allen ER et al. The sulfur cycle.
Science 1972; 175: 587–596
10. Luecken DJ, Napelenok SL, Strum M et al. Sensitivity of am-
bient atmospheric formaldehyde and ozone to precursor
species and source types across the United States. Environ
Sci Technol 2018; 52: 4668–4675
11. Orr SE, Bridges CC. Chronic kidney disease and exposure to
nephrotoxic metals. Int J Mol Sci 2017; 18
12. Xu X, Nie S, Ding H et al. Environmental pollution and kid-
ney diseases. Nat Rev Nephrol 2018; 14: 313–324
13. Brook RD, Rajagopalan S, Pope CA et al. Particulate matter
air pollution and cardiovascular disease: an update to the
scientific statement from the American Heart Association.
Circulation 2010; 121: 2331–2378
14. Guo Y, Li S, Tian Z et al. The burden of air pollution on years
of life lost in Beijing, China, 2004-08: retrospective regres-
sion analysis of daily deaths. BMJ 2013; 347: f7139
15. Zhang J, Liu Y, Cui LL et al. Ambient air pollution, smog epi-
sodes and mortality in Jinan, China. Sci Rep 2017; 7: 11209
16. Milojevic A, Wilkinson P, Armstrong B et al. Short-term
effects of air pollution on a range of cardiovascular events
in England and Wales: case-crossover analysis of the
MINAP database, hospital admissions and mortality. Heart
2014; 100: 1093–1098
17. Lawrence WR, Yang M, Lin S et al. Pet exposure in utero and
postnatal decreases the effects of air pollutants on hyper-
tension in children: A large population based cohort study.
Environ Pollut 2018; 238: 177–185
18. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and
the risks of death, cardiovascular events, and hospitaliza-
tion. N Engl J Med 2004; 351: 1296–1305
19. Yang YR, Chen YM, Chen SY et al. Associations between
long-term particulate matter exposure and adult renal
function in the Taipei Metropolis. Environ Health Perspect
2017; 125: 602–607
20. Kim HJ, Min JY, Seo YS et al. Association between exposure
to ambient air pollution and renal function in Korean
adults. Ann Occup Environ Med 2018; 30: 14
21. Zalups RK. Enhanced renal outer medullary uptake of mer-
cury associated with uninephrectomy: implication of a lumi-
nal mechanism. J Toxicol Environ Health 1997; 50: 173–194
22. Robles-Osorio ML, Sabath-Silva E, Sabath E. Arsenic-medi-
ated nephrotoxicity. Ren Fail 2015; 37: 542–547
23. Tsao DA, Tseng WC, Chang HR. RKIP expression of liver and
kidney after arsenic exposure. Environ Toxicol 2017; 32:
1079–1082
24. Aleksunes LM, Augustine LM, Scheffer GL et al. Renal xeno-
biotic transporters are differentially expressed in mice fol-
lowing cisplatin treatment. Toxicology 2008; 250: 82–88
25. Roggenbeck BA, Banerjee M, Leslie EM. Cellular arsenic
transport pathways in mammals. J Environ Sci (China) 2016;
49: 38–58
26. Beck KR, Ba¨chler M, Vuorinen A et al. Inhibition of 11beta-
hydroxysteroid dehydrogenase 2 by the fungicides itracon-
azole and posaconazole. Biochem Pharmacol 2017; 130: 93–103
27. Hossny E, Mokhtar G, El-Awady M et al. Environmental expo-
sure of the pediatric age groups in Cairo City and its suburbs
to cadmium pollution. Sci Total Environ 2001; 273: 135–146
28. Mortensen ME, Wong LY, Osterloh JD. Smoking status and
urine cadmium above levels associated with subclinical re-
nal effects in U.S. adults without chronic kidney disease. Int
J Hyg Environ Health 2011; 214: 305–310
29. Roels HA, Hoet P, Lison D. Usefulness of biomarkers of
exposure to inorganic mercury, lead, or cadmium in con-
trolling occupational and environmental risks of nephro-
toxicity. Ren Fail 1999; 21: 251–262
30. Felley-Bosco E, Diezi J. Fate of cadmium in rat renal tubules:
a microinjection study. Toxicol Appl Pharmacol 1987; 91:
204–211
31. Gała _zyn-Sidorczuk M, Brzo´ska MM, Jurczuk M et al.
Oxidative damage to proteins and DNA in rats exposed to
cadmium and/or ethanol. Chem Biol Interact 2009; 180: 31–38
32. Matovic V, Buha A, Ðukic-C´osic D et al. Insight into the oxi-
dative stress induced by lead and/or cadmium in blood,
liver and kidneys. Food Chem Toxicol 2015; 78: 130–140
33. So KY, Oh SH. Cadmium-induced heme-oxygenase-1 ex-
pression plays dual roles in autophagy and apoptosis and
is regulated by both PKC-delta and PKB/Akt activation in
NRK52E kidney cells. Toxicology 2016; 370: 49–59
34. Liu J, Liu Y, Habeebu SS et al. Metallothionein-null mice are
highly susceptible to the hematotoxic and immunotoxic
effects of chronic CdCl2 exposure. Toxicol Appl Pharmacol
1999; 159: 98–108
35. Brzo´ska MM, Roszczenko A, Gala _zyn-Sidorczuk M et al. Zinc
supplementation can protect from enhanced risk of femo-
ral neck fracture in male rats chronically exposed to cad-
mium. Exp Toxicol Pathol 2011; 63: 491–498
36. Jarup L, Persson B, Elinder CG. Decreased glomerular filtra-
tion rate in solderers exposed to cadmium. Occup Environ
Med 1995; 52: 818–822
37. Jarup L, Elinder CG. Incidence of renal stones among cad-
mium exposed battery workers. Br J Ind Med 1993; 50: 598–602
38. Iwata K, Saito H, Moriyama M et al. Renal tubular function
after reduction of environmental cadmium exposure: a
ten-year follow-up. Arch Environ Health 1993; 48: 157–163
39. Fujishiro H, Yano Y, Takada Y et al. Roles of ZIP8, ZIP14,
and DMT1 in transport of cadmium and manganese in
mouse kidney proximal tubule cells. Metallomics 2012; 4:
700–708
40. He L, Wang B, Hay EB et al. Discovery of ZIP transporters
that participate in cadmium damage to testis and kidney.
Toxicol Appl Pharmacol 2009; 238: 250–257
41. Jarup L, Berglund M, Elinder CG et al. Health effects of cad-
mium exposure–a review of the literature and a risk esti-
mate. Scand J Work Environ Health 1998; 24 (Suppl 1): 1–51
42. Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic
kidney disease. Toxicol Appl Pharmacol 2009; 238: 289–293
28 | B. Afsar et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/1/19/5162583 by U
niversidad Autonom
a de M
adrid user on 14 O
ctober 2019
43. Afridi HI, Kazi TG, Talpur FN et al. Interaction between es-
sential elements selenium and zinc with cadmium and
mercury in samples from hypertensive patients. Biol Trace
Elem Res 2014; 160: 185–196
44. Fowler BA, DuVal G. Effects of lead on the kidney: roles of
high-affinity lead-binding proteins. Environ Health Perspect
1991; 91: 77–80
45. Bogden JD, Gertner SB, Christakos S et al. Dietary calcium
modifies concentrations of lead and other metals and renal
calbindin in rats. J Nutr 1992; 122: 1351–1360
46. Blake KC, Mann M. Effect of calcium and phosphorus on the
gastrointestinal absorption of 203Pb in man. Environ Res
1983; 30: 188–194
47. Goyer RA. Mechanisms of lead and cadmium nephrotoxi-
city. Toxicol Lett 1989; 46: 153–162
48. Evans M, Elinder CG. Chronic renal failure from lead: myth
or evidence-based fact? Kidney Int 2011; 79: 272–279
49. Patrick L. Lead toxicity part II: the role of free radical dam-
age and the use of antioxidants in the pathology and treat-
ment of lead toxicity. Altern Med Rev 2006; 11: 114–127
50. Basgen JM, Sobin C. Early chronic low-level lead exposure
produces glomerular hypertrophy in young C57BL/6J mice.
Toxicol Lett 2014; 225: 48–56
51. Ca´rdenas A, Roels H, Bernard AM et al. Markers of early re-
nal changes induced by industrial pollutants. II.
Application to workers exposed to lead. Br J Ind Med 1993;
50: 28–36
52. Chung S, Chung JH, Kim SJ et al. Blood lead and cadmium
levels and renal function in Korean adults. Clin Exp Nephrol
2014; 18: 726–734
53. Bjorklund G, Dadar M, Mutter J et al. The toxicology of mer-
cury: current research and emerging trends. Environ Res
2017; 159: 545–554
54. Omata S, Sato M, Sakimura K et al. Time-dependent accu-
mulation of inorganic mercury in subcellular fractions of
kidney, liver, and brain of rats exposed to methylmercury.
Arch Toxicol 1980; 44: 231–241
55. Zalups RK. Early aspects of the intrarenal distribution of
mercury after the intravenous administration of mercuric
chloride. Toxicology 1993; 79: 215–228
56. Zalups RK, Ahmad S. Homocysteine and the renal epithelial
transport and toxicity of inorganic mercury: role of basolat-
eral transporter organic anion transporter 1. J Am Soc
Nephrol 2004; 15: 2023–2031
57. Zalups RK, Koropatnick J. Temporal changes in metallo-
thionein gene transcription in rat kidney and liver: rela-
tionship to content of mercury and metallothionein
protein. J Pharmacol Exp Ther 2000; 295: 74–82
58. Hodgson S, Nieuwenhuijsen MJ, Elliott P et al. Kidney dis-
ease mortality and environmental exposure to mercury.
Am J Epidemiol 2007; 165: 72–77
59. Nuyts GD, Van Vlem E, Thys J et al. New occupational risk
factors for chronic renal failure. Lancet 1995; 346: 7–11
60. Roszell LE, Hahn FF, Lee RB et al. Assessing the renal toxicity
of Capstone depleted uranium oxides and other uranium
compounds. Health Phys 2009; 96: 343–351
61. Shankar A, Klein R, Klein BE. The association among smok-
ing, heavy drinking, and chronic kidney disease. Am J
Epidemiol 2006; 164: 263–271
62. Xia J, Wang L, Ma Z et al. Cigarette smoking and chronic kid-
ney disease in the general population: a systematic review
and meta-analysis of prospective cohort studies. Nephrol
Dial Transplant 2017; 32: 475–487
63. Hall ME, Wang W, Okhomina V et al. Cigarette smoking and
chronic kidney disease in African Americans in the Jackson
Heart Study. J Am Heart Assoc 2016; 5
64. Hogan SL, Hogan SL, Vupputuri S et al. Association of ciga-
rette smoking with albuminuria in the United States: the
third National Health and Nutrition Examination Survey.
Ren Fail 2007; 29: 133–142
65. Pinto-Sietsma SJ, Mulder J, Janssen WM et al. Smoking is re-
lated to albuminuria and abnormal renal function in non-
diabetic persons. Ann Intern Med 2000; 133: 585–591
66. Chase HP, Garg SK, Marshall G et al. Cigarette smoking
increases the risk of albuminuria among subjects with type
I diabetes. JAMA 1991; 265: 614–617
67. Warmoth L, Regalado MM, Simoni J et al. Cigarette smoking
enhances increased urine albumin excretion as a risk factor
for glomerular filtration rate decline in primary hyperten-
sion. Am JMed Sci 2005; 330: 111–119
68. Noborisaka Y, Ishizaki M, Nakata M et al. Cigarette smoking,
proteinuria, and renal function in middle-aged Japanese
men from an occupational population. Environ Health Prev
Med 2012; 17: 147–156
69. Jiang N, Huang F, Zhang X. Smoking and the risk of diabetic
nephropathy in patients with type 1 and type 2 diabetes: a
meta-analysis of observational studies. Oncotarget 2017; 8:
93209–93218
70. Omoloja A, Jerry-Fluker J, Ng DK et al. Secondhand smoke
exposure is associated with proteinuria in children with
chronic kidney disease. Pediatr Nephrol 2013; 28: 1243–1251
71. Dulger H, Donder A, Sekeroglu MR et al. Investigation of the
relationship between serum levels of cotinine and the renal
function in active and passive smokers. Ren Fail 2011; 33:
475–479
72. Boor P, Casper S, Celec P et al. Renal, vascular and cardiac fi-
brosis in rats exposed to passive smoking and industrial
dust fibre amosite. J Cell Mol Med 2009; 13: 4484–4491
73. Orth SR. Effects of smoking on systemic and intrarenal he-
modynamics: influence on renal function. J Am Soc Nephrol
2004; 15 (Suppl 1): S58–S63
74. Markowitz GS, Lin J, Valeri AM et al. Idiopathic nodular glo-
merulosclerosis is a distinct clinicopathologic entity linked
to hypertension and smoking. Hum Pathol 2002; 33: 826–835
75. Ejerblad E, Fored CM, Lindblad P et al. Association between
smoking and chronic renal failure in a nationwide
population-based case-control study. J Am Soc Nephrol 2004;
15: 2178–2185
76. Tylicki L, Puttinger H, Rutkowski P et al. Smoking as a risk
factor for renal injury in essential hypertension. Nephron
Clin Pract 2006; 103: c121–c128
77. Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13:
1663–1672
78. Obert DM, Hua P, Pilkerton ME et al. Environmental tobacco
smoke furthers progression of diabetic nephropathy. Am J
Med Sci 2011; 341: 126–130
79. Jaimes EA, Tian RX, Raij L. Nicotine: the link between ciga-
rette smoking and the progression of renal injury? Am J
Physiol Heart Circ Physiol 2007; 292: H76–H82
80. Schwerdt G, Gordjani N, Benesic A et al. Chloroacetaldehyde-
and acrolein-induced death of human proximal tubule cells.
Pediatr Nephrol 2006; 21: 60–67
81. Jaimes EA, DeMaster EG, Tian RX et al. Stable compounds of
cigarette smoke induce endothelial superoxide anion pro-
duction via NADPH oxidase activation. Arterioscler Thromb
Vasc Biol 2004; 24: 1031–1036
Air pollution and kidney disease | 29
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/1/19/5162583 by U
niversidad Autonom
a de M
adrid user on 14 O
ctober 2019
82. Satarug S, Moore MR. Adverse health effects of chronic ex-
posure to low-level cadmium in foodstuffs and cigarette
smoke. Environ Health Perspect 2004; 112: 1099–1103
83. Visioli F, Galli C, Plasmati E et al. Olive phenol hydroxytyro-
sol prevents passive smoking-induced oxidative stress.
Circulation 2000; 102: 2169–2171
84. Culhaci N, Meteoglu I, Dundar M et al. Histopathological
evaluation of renal vascular changes in rats exposed to pas-
sive smoking. Pathol Oncol Res 2005; 11: 121–124
85. Lhotta K, Rumpelt HJ, Konig P et al. Cigarette smoking and
vascular pathology in renal biopsies. Kidney Int 2002; 61:
648–654
86. Lue SH, Wellenius GA, Wilker EH et al. Residential proximity
to major roadways and renal function. J Epidemiol
Community Health 2013; 67: 629–634
87. Hodgson S, Nieuwenhuijsen MJ, Hansell A et al. Excess risk
of kidney disease in a population living near industrial
plants. Occup Environ Med 2004; 61: 717–719
88. O’Neill MS, Diez-Roux AV, Auchincloss AH et al. Airborne
particulate matter exposure and urinary albumin excre-
tion: the Multi-Ethnic Study of Atherosclerosis. Occup
Environ Med 2008; 65: 534–540
89. Xu X, Wang G, Chen N et al. Long-term exposure to air pol-
lution and increased risk of membranous nephropathy in
China. J Am Soc Nephrol 2016; 27: 3739–3746
90. Bowe B, Xie Y, Li T et al. Particulate matter air pollution and
the risk of incident CKD and progression to ESRD. J Am Soc
Nephrol 2018; 29: 218–230
91. Mehta AJ, Zanobetti A, Bind MA et al. Long-term exposure
to ambient fine particulate matter and renal function in
older men: The Veterans Administration Normative Aging
Study. Environ Health Perspect 2016; 124: 1353–1360
92. Bowe B, Xie Y, Li T et al. Associations of ambient coarse par-
ticulate matter, nitrogen dioxide, and carbon monoxide
with the risk of kidney disease: a cohort study. Lancet Planet
Health 2017; 1: e267–e276
93. Brook RD. Why physicians who treat hypertension should
know more about air pollution. J Clin Hypertens (Greenwich)
2007; 9: 629–635
94. Choi J-H, Xu Q-S, Park S-Y et al. Seasonal variation of effect
of air pollution on blood pressure. J Epidemiol Community
Health 2007; 61: 314–318
95. Auchincloss AH, Diez Roux AV, Dvonch JT et al.
Associations between recent exposure to ambient fine par-
ticulate matter and blood pressure in the Multi-ethnic
Study of Atherosclerosis (MESA). Environ Health Perspect
2008; 116: 486–491
96. Ibald-Mulli A, Stieber J, Wichmann HE et al. Effects of air
pollution on blood pressure: a population-based approach.
Am J Public Health 2001; 91: 571–577
97. Dong GH, Qian Z, Xaverius PK et al. Association between
long-term air pollution and increased blood pressure and
hypertension in China. Hypertension 2013; 61: 578–584
98. Hoffmann B, Luttmann-Gibson H, Cohen A et al. Opposing
effects of particle pollution, ozone, and ambient tempera-
ture on arterial blood pressure. Environ Health Perspect 2012;
120: 241–246
99. van Rossem L, Rifas-Shiman SL, Melly SJ et al. Prenatal air
pollution exposure and newborn blood pressure. Environ
Health Perspect 2015; 123: 353–359
100. Zhang Z, Laden F, Forman JP et al. Long-term exposure to
particulate matter and self-reported hypertension: a pro-
spective analysis in the Nurses’ Health Study. Environ
Health Perspect 2016; 124: 1414–1420
101. Zhang Z, Guo C, Lau AKH et al. Long-term exposure to fine
particulate matter, blood pressure, and incident hyperten-
sion in Taiwanese adults. Environ Health Perspect 2018; 126:
017008
102. Yang B-Y, Qian Z, Vaughn MG et al. Is prehypertension
more strongly associated with long-term ambient air pollu-
tion exposure than hypertension? Findings from the 33
Communities Chinese Health Study. Environ Pollut 2017;
229: 696–704
103. Yang B-Y, Qian Z, Howard SW et al. Global association be-
tween ambient air pollution and blood pressure: a system-
atic review and meta-analysis. Environ Pollut 2018; 235:
576–588
104. Chuang KJ, Yan YH, Chiu SY et al. Long-term air pollution
exposure and risk factors for cardiovascular diseases
among the elderly in Taiwan. Occup Environ Med 2011; 68:
64–68
105. Giorgini P, Di Giosia P, Grassi D et al. Air pollution exposure
and blood pressure: an updated review of the literature.
Curr Pharm Des 2016; 22: 28–51
106. Dvonch JT, Kannan S, Schulz AJ et al. Acute effects of ambi-
ent particulate matter on blood pressure: differential
effects across urban communities. Hypertension 2009; 53:
853–859
107. Baccarelli A, Barretta F, Dou C et al. Effects of particulate air
pollution on blood pressure in a highly exposed population
in Beijing, China: a repeated-measure study. Environ Health
2011; 10: 108
108. Chen H, Burnett RT, Kwong JC et al. Spatial association be-
tween ambient fine particulate matter and incident hyper-
tension. Circulation 2014; 129: 562–569
109. Liu L, Ruddy TD, Dalipaj M et al. Influence of personal expo-
sure to particulate air pollution on cardiovascular physiol-
ogy and biomarkers of inflammation and oxidative stress
in subjects with diabetes. J Occup Environ Med 2007; 49:
258–265
110. Zanobetti A, Canner MJ, Stone PH et al. Ambient pollution
and blood pressure in cardiac rehabilitation patients.
Circulation 2004; 110: 2184–2189
111. Brook RD, Bard RL, Burnett RT et al. Differences in blood
pressure and vascular responses associated with ambient
fine particulate matter exposures measured at the personal
versus community level. Occup Environ Med 2011; 68:
224–230
112. Tsai D-H, Riediker M, Wuerzner G et al. Short-term increase
in particulate matter blunts nocturnal blood pressure dip-
ping and daytime urinary sodium excretion. Hypertension
2012; 60: 1061–1069
113. de Paula Santos U, Braga ALF, Giorgi DMA et al. Effects of air
pollution on blood pressure and heart rate variability: a
panel study of vehicular traffic controllers in the city of Sao
Paulo, Brazil. Eur Heart J 2005; 26: 193–200
114. Chuang KJ, Chan CC, Shiao GM et al. Associations between
submicrometer particles exposures and blood pressure and
heart rate in patients with lung function impairments.
J Occup Environ Med 2005; 47: 1093–1098
115. Zeng X-W, Qian Z, Vaughn MG et al. Positive association be-
tween short-term ambient air pollution exposure and chil-
dren blood pressure in China-Result from the Seven
Northeast Cities (SNEC) study. Environ Pollut 2017; 224:
698–705
116. Fuks KB, Weinmayr G, Foraster M et al. Arterial blood pres-
sure and long-term exposure to traffic-related air pollution:
an analysis in the European Study of Cohorts for Air
30 | B. Afsar et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/1/19/5162583 by U
niversidad Autonom
a de M
adrid user on 14 O
ctober 2019
Pollution Effects (ESCAPE). Environ Health Perspect 2014; 122:
896–905
117. Madsen C, Nafstad P. Associations between environmental
exposure and blood pressure among participants in the
Oslo Health Study (HUBRO). Eur J Epidemiol 2006; 21: 485–491
118. Harrabi I, Rondeau V, Dartigues JF et al. Effects of particulate
air pollution on systolic blood pressure: a population-based
approach. Environ Res 2006; 101: 89–93
119. Janghorbani M, Momeni F, Mansourian M. Systematic re-
view and metaanalysis of air pollution exposure and risk of
diabetes. Eur J Epidemiol 2014; 29: 231–242
120. Wang B, Xu D, Jing Z et al. Effect of long-term exposure to
air pollution on type 2 diabetes mellitus risk: a systemic re-
view and meta-analysis of cohort studies. Eur J Endocrinol
2014; 171: R173–R182
121. Balti EV, Echouffo-Tcheugui JB, Yako YY et al. Air pollution
and risk of type 2 diabetes mellitus: a systematic
review and meta-analysis. Diabetes Res Clin Pract 2014; 106:
161–172
122. Sohn D, Oh H. Gender-dependent differences in the rela-
tionship between diabetes mellitus and ambient air pollu-
tion among adults in South Korean cities. Iran J Public Health
2017; 46: 293–300
123. Rajagopalan S, Brook RD. Air pollution and type 2 diabetes:
mechanistic insights. Diabetes 2012; 61: 3037–3045
124. Rao X, Patel P, Puett R et al. Air pollution as a risk factor for
type 2 diabetes. Toxicol Sci 2015; 143: 231–241
125. Kra¨mer U, Herder C, Sugiri D et al. Traffic-related air pollu-
tion and incident type 2 diabetes: results from the SALIA
cohort study. Environ Health Perspect 2010; 118: 1273–1279
126. Coogan PF, White LF, Jerrett M et al. Air pollution and inci-
dence of hypertension and diabetes mellitus in black
women living in Los Angeles. Circulation 2012; 125: 767–772
127. Hansen AB, Ravnskjær L, Loft S et al. Long-term exposure to
fine particulate matter and incidence of diabetes in the
Danish Nurse Cohort. Environ Int 2016; 91: 243–250
128. Chen H, Burnett RT, Kwong JC et al. Risk of incident diabetes
in relation to long-term exposure to fine particulate matter
in Ontario, Canada. Environ Health Perspect 2013; 121:
804–810
129. Hassanvand MS, Naddafi K, Malek M et al. Effect of long-
term exposure to ambient particulate matter on prevalence
of type 2 diabetes and hypertension in Iranian adults: an
ecologic study. Environ Sci Pollut Res Int 2018; 25: 1713–1718
130. Strak M, Janssen N, Beelen R et al. Long-term exposure to
particulate matter, NO2 and the oxidative potential of par-
ticulates and diabetes prevalence in a large national health
survey. Environ Int 2017; 108: 228–236
131. Bowe B, Xie Y, Li T et al. The 2016 global and national bur-
den of diabetes mellitus attributable to PM2.5 air pollution.
Lancet Planet Health 2018; 2: e301–e312
132. Toledo-Corral CM, Alderete TL, Habre R et al. Effects of air
pollution exposure on glucose metabolism in Los Angeles
minority children. Pediatr Obes 2018; 13: 54–62
133. Turner MC, Jerrett M, Pope CA et al. Long-term ozone expo-
sure and mortality in a large prospective study. Am J Respir
Crit Care Med 2016; 193: 1134–1142
134. Vella RE, Pillon NJ, Zarrouki B et al. Ozone exposure triggers
insulin resistance through muscle c-Jun N-terminal kinase
activation. Diabetes 2015; 64: 1011–1024
135. Qiu H, Schooling CM, Sun S et al. Long-term exposure to fine
particulate matter air pollution and type 2 diabetes melli-
tus in elderly: a cohort study in Hong Kong. Environ Int 2018;
113: 350–356
136. Liu C, Yang C, Zhao Y et al. Associations between long-term
exposure to ambient particulate air pollution and type 2 di-
abetes prevalence, blood glucose and glycosylated hemo-
globin levels in China. Environ Int 2016; 92–93: 416–421
137. Pearson JF, Bachireddy C, Shyamprasad S et al. Association
between fine particulate matter and diabetes prevalence in
the U.S. Diabetes Care 2010; 33: 2196–2201
138. Puett RC, Hart JE, Schwartz J et al. Are particulate matter
exposures associated with risk of type 2 diabetes? Environ
Health Perspect 2011; 119: 384–389
139. Li W, Dorans KS, Wilker EH et al. Ambient air pollution, adi-
pokines, and glucose homeostasis: The Framingham Heart
Study. Environ Int 2018; 111: 14–22
140. Brook RD, Xu X, Bard RL et al. Reduced metabolic insulin
sensitivity following sub-acute exposures to low levels of
ambient fine particulate matter air pollution. Sci Total
Environ 2013; 448: 66–71
141. Chen L, Zhou Y, Li S et al. Air pollution and fasting blood
glucose: a longitudinal study in China. Sci Total Environ
2016; 541: 750–755
142. Ward-Caviness CK, Kraus WE, Blach C et al. Association of
roadway proximity with fasting plasma glucose and meta-
bolic risk factors for cardiovascular disease in a cross-
sectional study of cardiac catheterization patients. Environ
Health Perspect 2015; 123: 1007–1014
143. Wolf K, Popp A, Schneider A et al. Association between
long-term exposure to air pollution and biomarkers related
to insulin resistance, subclinical inflammation, and adipo-
kines. Diabetes 2016; 65: 3314–3326
144. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown
origin in Central America: the case for a Mesoamerican ne-
phropathy. Am J Kidney Dis 2014; 63: 506–520
145. Roncal-Jimenez CA, Garcia-Trabanino R, Wesseling C et al.
Mesoamerican nephropathy or global warming nephropa-
thy? Blood Purif 2016; 41: 135–138
146. Bodin T, Garcı´a-Trabanino R, Weiss I et al. Intervention to
reduce heat stress and improve efficiency among sugar-
cane workers in El Salvador: Phase 1. Occup Environ Med
2016; 73: 409–416
147. Stiborova M, Arlt VM, Schmeiser HH. Balkan endemic ne-
phropathy: an update on its aetiology. Arch Toxicol 2016; 90:
2595–2615
148. Stefanovic V, Radovanovic Z. Balkan endemic nephropathy
and associated urothelial cancer. Nat Clin Pract Urol 2008; 5:
105–112
149. Jadot I, Decle`ves AE, Nortier J et al. An integrated view of
aristolochic acid nephropathy: update of the literature. Int J
Mol Sci 2017; 18
150. Grollman AP, Jelakovic B. Role of environmental toxins in
endemic (Balkan) nephropathy. October 2006, Zagreb,
Croatia. J Am Soc Nephrol 2007; 18: 2817–2823
151. De Broe ME. Chinese herbs nephropathy and Balkan en-
demic nephropathy: toward a single entity, aristolochic
acid nephropathy. Kidney Int 2012; 81: 513–515
152. Cvitkovic A, Vukovic-Lela I, Edwards KL et al. Could disap-
pearance of endemic (Balkan) nephropathy be expected in
forthcoming decades? Kidney Blood Press Res 2012; 35:
147–152
153. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid
nephropathy: a worldwide problem. Kidney Int 2008; 74:
158–169
154. Reginster F, Jadoul M, van Ypersele de Strihou C. Chinese
herbs nephropathy presentation, natural history and fate
after transplantation. Nephrol Dial Transplant 1997; 12: 81–86
Air pollution and kidney disease | 31
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/1/19/5162583 by U
niversidad Autonom
a de M
adrid user on 14 O
ctober 2019
155. Depierreux M, Van Damme B, Vanden Houte K et al.
Pathologic aspects of a newly described nephropathy re-
lated to the prolonged use of Chinese herbs. Am J Kidney Dis
1994; 24: 172–180
156. Pope CA 3rd, Dockery DW. Health effects of fine particulate
air pollution: lines that connect. J Air Waste Manag Assoc
2006; 56: 709–742
157. Brook RD. Cardiovascular effects of air pollution. Clin Sci
(Lond) 2008; 115: 175–187
158. Fukuda M, Goto N, Kimura G. Hypothesis on renal mecha-
nism of non-dipper pattern of circadian blood pressure
rhythm. Med Hypotheses 2006; 67: 802–806
159. Alexeeff SE, Coull BA, Gryparis A et al. Medium-term expo-
sure to traffic-related air pollution and markers of inflam-
mation and endothelial function. Environ Health Perspect
2011; 119: 481–486
160. Suwa T, Hogg JC, Quinlan KB et al. Particulate air pollution
induces progression of atherosclerosis. J Am Coll Cardiol
2002; 39: 935–942
161. Sun Q, Wang A, Jin X et al. Long-term air pollution exposure
and acceleration of atherosclerosis and vascular inflamma-
tion in an animal model. JAMA 2005; 294: 3003–3010
162. Bauer M, Moebus S, Mo¨hlenkamp S et al. Urban particulate
matter air pollution is associated with subclinical athero-
sclerosis: results from the HNR (Heinz Nixdorf Recall)
study. J Am Coll Cardiol 2010; 56: 1803–1808
163. Diez Roux AV, Auchincloss AH, Franklin TG et al. Long-term
exposure to ambient particulate matter and prevalence of
subclinical atherosclerosis in the Multi-Ethnic Study of
Atherosclerosis. Am J Epidemiol 2008; 167: 667–675
164. Lemos M, Mohallen SV, Macchione M et al. Chronic expo-
sure to urban air pollution induces structural alterations in
murine pulmonary and coronary arteries. Inhal Toxicol 2006;
18: 247–253
165. Yan Y-H, Chou CC-K, Wang J-S et al. Subchronic effects of
inhaled ambient particulate matter on glucose homeosta-
sis and target organ damage in a type 1 diabetic rat model.
Toxicol Appl Pharmacol 2014; 281: 211–220
166. Schwartz J. Air pollution and blood markers of cardiovascu-
lar risk. Environ Health Perspect 2001; 109 (Suppl 3): 405–409
167. Dockery DW. Epidemiologic evidence of cardiovascular
effects of particulate air pollution. Environ Health Perspect
2001; 109 (Suppl 4): 483–486
168. Peters A, Doring A, Wichmann HE et al. Increased plasma
viscosity during an air pollution episode: a link to mortal-
ity? Lancet 1997; 349: 1582–1587
169. Franchini M, Mannucci PM. Thrombogenicity and cardio-
vascular effects of ambient air pollution. Blood 2011; 118:
2405–2412
170. Sun Q, Hong X, Wold LE. Cardiovascular effects of ambient
particulate air pollution exposure. Circulation 2010; 121:
2755–2765
171. Orth SR, Hallan SI. Smoking: a risk factor for progression of
chronic kidney disease and for cardiovascular morbidity
and mortality in renal patients–absence of evidence or evi-
dence of absence? Clin J Am Soc Nephrol 2008; 3: 226–236
172. EL-Safty IAM, Afifi AMH, Shouman AE et al. Effects of smok-
ing and lead exposure on proximal tubular integrity among
Egyptian industrial workers. Arch Med Res 2004; 35: 59–65
173. Sun L, Liu C, Xu X et al. Ambient fine particulate matter and
ozone exposures induce inflammation in epicardial and
perirenal adipose tissues in rats fed a high fructose diet.
Part Fibre Toxicol 2013; 10: 43
174. Sun Q, Yue P, Deiuliis JA et al. Ambient air pollution exag-
gerates adipose inflammation and insulin resistance in a
mouse model of diet-induced obesity. Circulation 2009; 119:
538–546
175. Xu X, Liu C, Xu Z et al. Long-term exposure to ambient fine
particulate pollution induces insulin resistance and mito-
chondrial alteration in adipose tissue. Toxicol Sci 2011; 124:
88–98
176. Xu Z, Xu X, Zhong M et al. Ambient particulate air pollution
induces oxidative stress and alterations of mitochondria
and gene expression in brown and white adipose tissues.
Part Fibre Toxicol 2011; 8: 20
177. Dubowsky SD, Suh H, Schwartz J et al. Diabetes, obesity,
and hypertension may enhance associations between air
pollution and markers of systemic inflammation. Environ
Health Perspect 2006; 114: 992–998
178. Meigs JB, Hu FB, Rifai N et al. Biomarkers of endothelial dys-
function and risk of type 2 diabetes mellitus. JAMA 2004;
291: 1978–1986
179. Piya MK, McTernan PG, Kumar S. Adipokine inflammation
and insulin resistance: the role of glucose, lipids and endo-
toxin. J Endocrinol 2013; 216: T1–T15
180. Zheng Z, Xu X, Zhang X et al. Exposure to ambient particu-
late matter induces a NASH-like phenotype and impairs
hepatic glucose metabolism in an animal model. J Hepatol
2013; 58: 148–154
181. Landrigan PJ, Fuller R, Hu H. Pollution and Global Health -
An Agenda for Prevention. Environ Health Perspect 2018; 126:
084501
32 | B. Afsar et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/ckj/article-abstract/12/1/19/5162583 by U
niversidad Autonom
a de M
adrid user on 14 O
ctober 2019
